haplo-identical hematopoietic stem cells
Cell therapyexperimental
Clinical trial activity
4 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
3
Phase 3
0
Phase 4
0
Earliest trial started Aug 1, 2005 (NCT00143559)
Timeline
2000s
- Jan 1, 2005
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
- Allografts · Phase 2
- Hematologic Diseases · Phase 2
- Hematopoietic Stem Cell Transplantation · Phase 2
- Hemoglobinuria, Paroxysmal · Phase 2
- Hodgkin Disease · Phase 2
- Leukemia · Phase 2
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive · Phase 2
- Leukemia, Myeloid, Acute · Phase 2
- Leukemia, Myelomonocytic, Juvenile · Phase 2
- Lymphoma, Non-Hodgkin · Phase 2
- Myelodysplastic Syndromes · Phase 2
- Precursor Cell Lymphoblastic Leukemia-Lymphoma · Phase 2
Mechanism of action
- Stem CellSupplementation
Stem Cell supplementation
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- haploidentical hematopoietic stem cell graft
- haplo-identical hematopoietic stem cells
- haploidentical hematopoietic stem cells
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05126186 | Phase 2 | Dec 1, 2021 | Assistance Publique - Hôpitaux de Paris |
| NCT02782546 | Phase 2 | Jan 30, 2017 | Washington University in St. Louis |
| NCT02126046 | N/A | Sep 1, 2012 | Southern Medical University |
| NCT00143559 | Phase 2 | Aug 1, 2005 | St. Jude Children's Hospital |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Assistance Publique - Hôpitaux de Paris | Academic/Hospital | 1 | 1 | 1 | 2021 |
| Southern Medical University | Academic/Hospital | 1 | 1 | 1 | 2012 |
| St. Jude Children's Hospital | Academic/Hospital | 1 | 1 | 1 | 2005 |
| Washington University in St. Louis | Academic/Hospital | 1 | 1 | 1 | 2017 |
4 organizations
Page 1 / 1